Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test breakthrough could spot ALS faster

NCT ID NCT07091799

First seen Jan 16, 2026 · Last updated Jun 19, 2026 · Updated 19 times

Summary

This study is testing whether measuring a specific protein (P2X4) on blood cells can help diagnose ALS, a serious nerve disease that causes muscle weakness and paralysis. Researchers will compare P2X4 levels in 50 people with ALS to those without the disease. If successful, this could lead to a faster, simpler diagnostic tool.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS & OTHER NEUROMUSCULAR DISORDERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Pellegrin

    RECRUITING

    Bordeaux, 33000, France

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

The condition(s) this trial relates to.

amyotrophic lateral sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.